Heading Health
Heading Health is an Austin-based, insurance-accepting mental health platform operating five Texas clinics and statewide telehealth, delivering Spravato, TMS, ketamine, psychiatry, and therapy to adults with treatment-resistant depression, PTSD, OCD, and related conditions.
- Company typePrivate
- Founded2020
- HeadquartersAustin, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Heading Health does
Heading Health is a Texas-based, insurance-accepting mental health platform that delivers multi-modal treatment for adults with treatment-resistant depression, PTSD, OCD, panic disorder, and bipolar depression. Founded in 2020 and headquartered in Austin, the company operates five physical clinics across Austin, Dallas/Fort Worth, and San Antonio, complemented by statewide telepsychiatry and teletherapy coverage. Its core clinical offerings are FDA-approved Spravato (esketamine nasal spray) and Transcranial Magnetic Stimulation (TMS), supplemented by sublingual ketamine, talk therapy, and a nutritional therapy module.
The technology stack centers on a hybrid in-person and virtual care delivery model supported by a HIPAA-compliant outcome-tracking application (Blueprint), a patient portal and EHR (AdvancedMD), and digital intake and billing software (Phreesia), with Zocdoc used for third-party scheduling. Heading Health does not develop proprietary clinical AI but leverages these workflow tools to coordinate care, verify insurance, and measure patient outcomes over time. The company maintains HIPAA compliance and participates in the FDA-mandated Spravato REMS program.
The business model is predominantly fee-for-service clinical revenue reimbursed by major commercial and government insurers (United Healthcare, CIGNA, TRICARE, Blue Cross Blue Shield, Aetna, Humana, Amerigroup, Molina, and Medicare), with self-pay options and a manufacturer copay assistance program (Spravato withMe) for uninsured or under-insured patients. Patients are acquired through a direct-to-consumer website with online intake, a dedicated phone line, and inbound referrals from external physicians and therapists. The company has raised approximately $11.5M cumulatively across seed, Series A extension, and strategic rounds led by SeedtoB Capital, Gron Ventures, JAM Fund, Global Brain, and BrainsWay, and acquired KindMind in 2022 to scale clinical capacity.
Heading Health firmographics
Firmographics- Name
- Heading Health
- Legal name
- Heading Health
- Website
- https://headinghealth.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Heading Health is an Austin-based, insurance-accepting mental health platform operating five Texas clinics and statewide telehealth, delivering Spravato, TMS, ketamine, psychiatry, and therapy to adults with treatment-resistant depression, PTSD, OCD, and related conditions.
- Ownership category
- akta.pro rank
Heading Health industry classification
Industry- Product category
- Mental Health Services
- NAICS
- Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Psychiatry & Medication Management Platforms (HLALAEAB)
Keywords
Where Heading Health is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Heading Health business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Insurance-Reimbursed Clinical Services: The majority of Heading Health's revenue comes from insurance reimbursement. The company is in-network with most major insurance plans including United Healthcare, CIGNA, TRICARE, Blue Cross Blue Shield, Aetna, Humana, Amerigroup, Molina, and Medicare. Services billed include psychiatry consultations, therapy sessions, Spravato treatments, TMS treatments, and ketamine-assisted therapy.
- Self-Pay / Out-of-Pocket Payments: Patients without insurance coverage can pay out-of-pocket for treatments. Spravato self-pay pricing is typically $800-$900 per treatment plus office visit costs. Sublingual ketamine is also available on a self-pay basis. Payment plans are offered for patients with large balances.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Insurance-covered treatment (in-network) |
| Unit Pricing | Pay-as-you-go | Spravato self-pay (without insurance) |
| Other | Pay-as-you-go | Spravato withMe Patient Savings Program |
| Other | Pay-as-you-go | Self-pay for uninsured patients |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Heading Health product offering
Product offeringCore offering
Heading Health is a mental healthcare provider that delivers in-person and virtual psychiatric care, with a focus on innovative treatments for treatment-resistant depression and related conditions. The company offers Spravato (esketamine nasal spray), Transcranial Magnetic Stimulation (TMS), sublingual ketamine, telepsychiatry, teletherapy, and nutritional therapy, accepting most major insurance plans to make advanced mental health treatments accessible.
Product overview
Heading Health is a mental healthcare provider offering a multi-modal treatment platform centered on innovative neuromodulation and pharmacological therapies. The core offerings include Spravato® (FDA-approved esketamine nasal spray) and Transcranial Magnetic Stimulation (TMS) for treatment-resistant depression, complemented by sublingual ketamine treatments. These in-clinic treatments are integrated with telepsychiatry and teletherapy services for ongoing medication management and counseling, while Nutritional Therapy serves as an additional supportive module. The company accepts most major insurance plans and operates clinics in Austin, Dallas, and San Antonio, Texas.
Differentiator
Problem solved
Functional benefit
Products and services
- Spravato®
Quantifiable outcome
- 69% response rate and 52% remission rate in patients treated with Spravato in clinical trials
- +3 more outcomes
Companies that use Heading Health
Customer profileSegments3 records
Ideal customer profiles2 records
Heading Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature3 records
Heading Health partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and supporting.
- Spravato REMS ProgramcoreHeading Health participates in the Spravato REMS (Risk Evaluation and Mitigation Strategy) program, a mandatory FDA requirement for prescribing Spravato (esketamine). All patients must enroll in the REMS program before starting Spravato treatment.
- SPRAVATO withMe Patient Savings ProgramcoreHeading Health facilitates enrollment in the SPRAVATO withMe patient savings program, which reduces the out-of-pocket cost of Spravato medication to $10/treatment for eligible patients. Savings can backdate up to 9 months. Heading helps patients enroll and handles rebate claim processing on their behalf.
- AdvancedMD (Patient Portal)coreHeading Health uses the AdvancedMD platform for its patient portal, which handles appointment scheduling, health records, billing, and secure messaging between patients and care teams.
- Phreesia (Intake Management)supportingHeading Health uses Phreesia software for digital patient check-in, forms management, and billing. Phreesia sends patients timely reminders, links, and opportunities to complete intake forms, billing, and copays.
- Blueprint (Outcome Tracking)supportingHeading Health uses the Blueprint app to enable patients and providers to track treatment progress over time. Blueprint is HIPAA-compliant and helps inform treatment decisions by measuring outcomes.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Heading Health competitors and assessment
Company assessmentDirect peers
- Nue Life: Nue Life is a ketamine therapy platform combining virtual psychiatry with at-home and supervised ketamine protocols. It overlaps with Heading Health on ketamine-assisted treatment for depression and anxiety.
- Mindbloom: Mindbloom is a leading at-home ketamine therapy platform serving treatment-resistant depression and anxiety. It is a direct competitor to Heading Health's ketamine offering, though it operates primarily via in-home sessions rather than in-clinic administration.
- Klarity Health: Klarity is a multi-state ketamine and integrative psychiatry provider with both telehealth and in-clinic delivery. It directly overlaps with Heading Health's psychiatry + ketamine combination model and serves similar treatment-resistant populations.
- Innerwell: Innerwell delivers ketamine-assisted psychotherapy through a hybrid virtual + in-person model. It competes directly with Heading Health for ketamine-assisted treatment patients in overlapping metro areas.
- Greenbrook TMS: Greenbrook operates a national network of outpatient TMS treatment centers. It is a direct competitor in the TMS segment of Heading Health's offering, with significantly larger geographic reach across the US and Canada.
Emerging players
- Lyra Health: Lyra Health is an employer-sponsored mental health benefit platform offering therapy, coaching, and psychiatry. It overlaps with Heading Health on the employer/payer channel and virtual psychiatry, but does not deliver in-clinic Spravato/TMS/ketamine.
- Spring Health: Spring Health is an employer mental health benefits provider combining therapy, coaching, and medication management. It is a partial competitor via its employer channel and virtual psychiatry, though it does not operate in-clinic advanced treatment centers.
Broad incumbents
- Cerebral: Cerebral is a national online mental health provider offering therapy and medication management. It overlaps with Heading Health on the telepsychiatry intake and therapy layer but does not focus on treatment-resistant depression or in-clinic advanced treatments.
- Talkspace: Talkspace is a publicly-traded online therapy and psychiatry platform. It competes for general mental health demand and virtual therapy referrals but does not deliver Spravato/TMS/ketamine or treat treatment-resistant depression as a specialty.
- BetterHelp: BetterHelp (a Teladoc Health subsidiary) is the largest direct-to-consumer online therapy marketplace. It is an adjacent incumbent competing for general mental health consumer demand, but does not overlap on in-clinic advanced treatments or treatment-resistant populations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Heading Health social profiles
Digital presenceHeading Health compliance and trust
Trust signalCompliance1 record
Heading Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Heading Health leadership team
Management profileNumber of profiles
Profiles4 records
Heading Health funding detail
Funding detailFunding overview
Funding rounds8 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Heading Health M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Heading Health
What does Heading Health do?
Heading Health is a mental healthcare provider that delivers in-person and virtual psychiatric care, with a focus on innovative treatments for treatment-resistant depression and related conditions. The company offers Spravato (esketamine nasal spray), Transcranial Magnetic Stimulation (TMS), sublingual ketamine, telepsychiatry, teletherapy, and nutritional therapy, accepting most major insurance plans to make advanced mental health treatments accessible.
Is Heading Health a public or private company?
Heading Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Heading Health founded?
Heading Health was founded in 2020. It employs 51 to 100 people.
Where is Heading Health based?
Heading Health is headquartered in Austin, United States, in the North America region.
How does Heading Health make money?
Two revenue lines are on record. Insurance-Reimbursed Clinical Services are the primary driver. The others are self-Pay / Out-of-Pocket Payments.
Who are Heading Health's main competitors?
Direct peers on record are Nue Life, Mindbloom, Klarity Health, Innerwell and Greenbrook TMS. Emerging players are Lyra Health and Spring Health. Broad incumbents are Cerebral, Talkspace and BetterHelp.
Does Heading Health have an API?
No public API is recorded for Heading Health.
What industry is Heading Health in?
Heading Health's product category is Mental Health Services. Its primary akta.pro industry code is HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 621112 and its SIC code is 8011.